Green Room offers now web design and content on top of health tech strategy consulting. While our look is new, our teams’ decades-long commitment to and reputation for
Despite a tough year in 2022 for health tech early-stage companies and markets in general, the trend that took flight in 2020 and 2021 in
Crypto or biotech – Both are high risk and high reward investments. Bob Teague, MD layouts out the pros and cons for investors battered
DexCare, the digital care operating system that was spun out of Providence Health last March, has raised $50 million in series B funding for its
If you’ve been following our updates, you know 2021 was a (the!) year for digital health venture funding: In July, we reported that the year
A closer look at the funding vehicles driving the VC-backed health tech and biotech markets and the pitfalls for the average investor entering 2022
A look back on the year that was for the healthcare industry and peek ahead for the digital health market in 2022 as we enter
Funding announcements in health innovation have been coming in hot and fast these days. It’s easy to lose perspective about where we’ve come from and
H1 2021 secured $14.7B in digital health funding, already surpassing all of 2020’s funding. The half closed with 372 deals and an average deal size
2021 opened with a whirlwind of SPAC-triggered public exit activity in digital health. In this post, we share insights and analysis on how digital health’s
PO Box 637
Austin, Texas
[email protected]
By providing your contact information you consent to receiving emails & information from Green Room Technologies.
No Spam. We respect your privacy & you may unsubscribe at any time.
